期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

艰难梭菌的生物学特性与实验室诊断 被引量：11

Biological characteristics and laboratory diagnosis of Clostridium difficile
在线阅读 下载PDF
导出
摘要 艰难梭菌感染（clostridium-di f ficile infection）是指艰难梭菌所致的感染。它是导致医院内抗菌药物相关性腹泻（AAD）的最重要因素之一，约20％的AAD由艰难梭菌感染引起，故又称艰难梭菌相关性腹泻（Clostridium di f ficile- associated diarrhea, CDAD）。艰难梭菌感染的确诊依赖于检出艰难梭菌或艰难梭菌毒素，国内相关的研究较少。现就艰难梭菌的生物学特性、实验室检测方法及其进展进行综述。
作者 杨雪妹 吴允孚
机构地区 南京医科大学附属苏州市立医院东区重症医学科
出处 《中国感染与化疗杂志》 CAS 北大核心 2013年第3期232-234,共3页 Chinese Journal of Infection and Chemotherapy
关键词 艰难梭菌 生物学特性 致病特点 实验室诊断
分类号 R378.8 [医药卫生—病原生物学]
  • 相关文献

参考文献22

  • 1Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea[J]. Arch Intern Med,2002,162(19) :2177-2184.
  • 2Larson KC, Belliveau PP, Spooner LM. Tigecycline for the treatment of severe Clostridium difficile infection [J]. Ann Pharmacother,2011,45(7-8) : 1005-1010.
  • 3Dodson AP, Borriello SP. Clostridium difficile infection of the gut [J]. J Clin Pathol,1996,49(7): 529-532.
  • 4Lyerly DM, Saum KE, MacDonald DK, et al. Effects of Clostridium difficile toxins given intragastrically to animals [J]. Infect Immun, 1985,47(2) 349-352.
  • 5Lyras D,O Connor JR,Howarth PM,et al. Toxin B is essential for virulence of Clostridium difficile [J]. Nature,2009, 458(7242):1176-1179.
  • 6Pituch H, van den Braak N, van Leeuwen W,et al. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland[J]. Clin Microbiol Infect, 2001, 7(8): 442-446.
  • 7Perelle S, Gibert M, Bourlioux P, et al. Production of a complete binary toxin (actin-specific ADP ribosyltransferase) by Clostridium difficile CD196 [J]. Infect Immun, 1997, 65 (4): 1402-1407.
  • 8Poxton IR, McCoubrey J, Blair G. The pathogenicity of Clostridium difficile [J]. Clin Microbiol Infect, 2001,7 (8) : 421-427.
  • 9Cohen RS, DiMarino AJ Jr, Allen ML. Fecal Clostridium difficile carriage among medical housestaff [J]. N J Med,1994,91(5): 327-330.
  • 10Loo VG, Poirier L, Miller MA, et al. A predominantly clon al multi-institutional outbreak of Clostridium difficile-asso-eiated diarrhea with high morbidity and mortality[J]. N Engl J Med,2005,353(23) : 2442-2449.

二级参考文献5

  • 1王传涛,刘道杰,王术皓.量子点在标记免疫分析中的应用研究进展[J].临床检验杂志,2007,25(1):73-74. 被引量：9
  • 2Ackermann G,Thomalla S, Ackermann F,et al. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhea[J]. J Med Microbiol,2005,54(Pt 2) : 149-153.
  • 3Zheng L, Keller SF, Lyerly DM, et al. Multieenter evaluation of a new screening test that detects Clostridium difficile in fecal speeimens[J]. J Clin Mierobiol, 2004,42 (8) : 3837-3840.
  • 4Asha NJ,Tompkins D,Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of anti- biotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus[J]. J Clin Microbiol, 2006,44 (8) : 2785-2791.
  • 5Krause R, Reisinger EC. Candida and antibiotic-associated diarrhoea[J]. Clin Microbiol Infect,2005(1) ,11:1-2.

共引文献4

同被引文献115

  • 1Edward C Oldfield Ⅳ,Edward C Oldfield Ⅲ,David A Johnson.Clinical update for the diagnosis and treatment of Clostridium difficile infection[J].World Journal of Gastrointestinal Pharmacology and Therapeutics,2014,5(1):1-26. 被引量：6
  • 2杨娟,郑青山.Meta分析的统计学方法[J].中国临床药理学与治疗学,2005,10(11):1309-1314. 被引量：60
  • 3李影林.中华医学检验全书[M].北京：人民卫生出版社,1996.357.
  • 4Willems L, Porcher R, Lafaurie M, et al. Clostridium difficile in- fection after allogeneic hematopoietic stem cell transplantation: in- cidence, risk factors, and outcome[ J]. Biol Blood Marrow Trans- plant, 2012, 18(8) : 1295-1301.
  • 5Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infec- tion: new developments in epidemiology and pathogenesis [ J ]. Nat Rev Microbiol, 2009, 7 (7) : 526-536.
  • 6Larson KC, Belliveau PP, Spooner LM. Tigecycline for the treat-ment of severe Clostridium difficile infection[ J]. Ann Pharmacoth- er, 2011,45(7-8) : 1005-1010.
  • 7Chakrabarti S, Lees A, Jones SG, et al. Clostridium difficile infec- tion in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality [ J ]. Bone Marrow Transplant, 2000, 26( 8): 871-876.
  • 8Kinnebrew MA, Lee YJ, Jenq RR, et al. Early Clostridium diffi- cile infection during allogeneic hematopoietic stem cell transplanta- tion[J]. PLoS One, 2014, 9(3) : e90158.
  • 9Callejas-Dlaz A, Gea-Banacloche JC. Clostridium difficile: delete- rious impact on hematopoietic stem cell transplantation [ J ]. Curr Hematol Malig Rep, 2014, 9(1): 85-90.
  • 10Alonso CD, Treadway SB, Hanna DB, et al. Epidemiology and outcomes of Clostridium diJficile infections in hematopoietic stem cell transplant recipients [ J]. Clin Infect Dis, 2012, 54 (8) : 1053-1063.

引证文献11

二级引证文献20

中国感染与化疗杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部